CardioDx Inc. raised $57.5 million from equity and options investments, according to its latest filing with the Securities & Exchange Commission.
The Palo Alto, Calif.-based genomics firm is developing tests based on gene expression analysis to measure patients’ risk for cardiovascular diseases.
The new financing, which is part of the $78.3 million the company is trying to raise, was supported by 17 unnamed investors, according to the SEC filing.
CardioDx’s previous investors include Kleiner Perkins Caufield & Byers, TPG Biotech, MDV, Intel Capital, Pappas Ventures, DAG Ventures, Asset Management Group and GE Capital. New investor Longitude Capital participated in the latest round, Xconomy reported.
Here’s a roundup of the latest dealflow and investment news:
- Nephros raises $3.2 million through rights offering and private placement
River Edge, N.J.-based Nephros Inc. (OTC:NEPH) completed its rights offering and private placement that together will result in gross proceeds of approximately $3.2 million. Nephros’ stockholders bought $2.0 million in units of its rights offering and the company’s largest stockholder, Lambda Investors LLC, agreed to purchase a private placement worth $1.2 million. The company commenced the rights offering on Jan. 31, according to an SEC filing.
- Image Stream pulls in $2 million
Image Stream Medical Inc. raised $2 million in an equity-based offering, according to an SEC filing. Only one unnamed investor participated in the round. The Littleton, Mass.-based medical device company develops medical image management technology for hospital operating rooms and video editing software for clinicians.
- Stimatix GI raises $1 million
Misgav, Israel-based Stimatix GI successfully concluded an investment round to support First-in-Man clinical trials. Pontifax, a venture capital fund chaired by Eli Hurvitz, invested $1 million in Stimatix GI. The company’s AOS-C1000 colostomy management system is designed to allow individuals to discretely manage their colostomy without the need to wear a traditional ostomy pouch.
- Rotech Healthcare Inc. plans senior second lien note private offering of $290 million
Orlando, Fla.-based Rotech Healthcare Inc. (OTC:ROHI) intends to offer, subject to market and other conditions, $290 million in aggregate principal amount of Senior Second Lien Notes due 2018. Rotech expects to use the net proceeds received from the offering to repay all of its Senior Subordinated Notes due 2012, for payment of related fees and expenses and for general corporate purposes, as applicable, including funding the company’s strategic priorities. The notes will be offered only to qualified institutional buyers.